Is SQZ Biotechnologies Co (SQZ) a Good Buy in the Healthcare Sector?

Friday, March 24, 2023 02:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is SQZ Biotechnologies Co (SQZ) a Good Buy in the Healthcare Sector?

The 62 rating InvestorsObserver gives to SQZ Biotechnologies Co (SQZ) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 72 percent of stocks in the Healthcare sector, SQZ’s 62 overall rating means the stock scores better than 62 of all stocks.

SQZ has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on SQZ!

See Full SQZ Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With SQZ Biotechnologies Co Stock Today?

SQZ Biotechnologies Co (SQZ) stock is lower by -25.62% while the S&P 500 is higher by 0.38% as of 2:36 PM on Friday, Mar 24. SQZ is lower by -$0.20 from the previous closing price of $0.80 on volume of 1,773,026 shares. Over the past year the S&P 500 is down -12.31% while SQZ is lower by -87.98%. SQZ lost -$2.76 per share the over the last 12 months. Click Here to get the full Stock Report for SQZ Biotechnologies Co stock.